Target intelligence / Profile preview

Pathogen cell wall

Molecular classification
Other
01

Overview

The term "Pathogen cell wall" is broad and non-specific, commonly referring to the carbohydrate- and protein-rich extracellular matrix surrounding cells of pathogenic bacteria, fungi, and some other microorganisms. In bacteria, the cell wall is primarily composed of peptidoglycan, which gives structural strength and determines shape; in Gram-positive types, the wall is thick and includes teichoic acids, while in Gram-negative bacteria, it is thinner and overlaid by an outer membrane containing lipopolysaccharide[1][3][6]. In fungi, the cell wall consists mainly of chitin and glucans, with various mannoproteins and, in some species, an additional polysaccharide capsule[2][6]. In plants, the cell wall is made of cellulose, hemicellulose, and pectin[4][5], but this is not typically considered a "pathogen cell wall." The cell wall serves as a critical therapeutic target because it is essential for microbial viability and absent in animal cells, allowing for selective toxicity. Numerous antibiotics and antifungal agents disrupt biosynthesis or integrity of the cell wall, resulting in pathogen death or growth inhibition. However, the term "Pathogen cell wall" is not a specific molecular entity—rather, it refers to a structural feature common to many, but not all, pathogens. Within drug discovery and therapeutics, actual targets are typically specific biosynthetic enzymes or assembly proteins (e.g., penicillin-binding proteins, beta-(1,3)-glucan synthase) rather than the cell wall structure as a whole. Note: - is_incorrect: true — The term “Pathogen cell wall” does not refer to a unique molecular target but rather a class of structures with diverse composition across various organisms. Proper targets would be specific cell wall biosynthetic enzymes or structural proteins in specific pathogens. - canonical_abbreviation: null — There is no standard abbreviation, as this is not a single molecular entity. - aliases include several generic or organism-specific names, as context varies.

Other names
Bacterial cell wallFungal cell wallMicrobial cell wallPlant cell wall
02

Mechanism of action

Inhibition of peptidoglycan synthesis (bacteria); inhibition of beta-glucan/chitin synthesis (fungi); disruption of cell wall cross-linking; increased cell wall permeability leading to cell lysis (sometimes by enzymatic degradation).

03

Biological functions

Structural integrityShape maintenanceDefense against environmental stressModulation of host immune responseCell division (in pathogens)Osmoregulation
04

Disease associations

Infection (pathogens)Antimicrobial resistanceImmune evasionPathogenicity
05

Safety considerations

Selectivity: most drugs targeting the microbial cell wall are highly selective, but off-target effects are possible with microbiota disruptionHypersensitivity/allergic reactions (e.g., beta-lactams)Emergence of resistance (e.g. MRSA, VRE, beta-lactamase-producing bacteria, echinocandin-resistant fungi)Effects on commensal organisms (microbiome disruption)Jarisch-Herxheimer reaction (due to rapid lysis of pathogens and release of cell wall components)
06

Interacting drugs

Beta-lactam antibiotics (e.g., penicillin, cephalosporins; target bacterial cell wall)

5 more in the full profile.

07

Biomarkers

Peptidoglycan (marker for bacterial infection)Chitin, beta-glucan (fungal infection markers)Lipopolysaccharide (Gram-negative bacteria)Teichoic acids (Gram-positive bacteria)Mannan (fungi)

Beyond the preview

Go deeper on Pathogen cell wall.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogen cell wall.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call